Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.1M | $4.5M | $4.7M | $6.8M | $8.2M | $9.2M | $9.2M | $9.2M |
| Cost of revenue | $3.1M | $3.3M | $3.4M | $3.8M | $3.9M | $3.9M | $3.7M | $3.3M |
| Gross profit | −$89.0K | $1.2M | $1.2M | $3.1M | $4.3M | $5.3M | $5.5M | $5.9M |
| Gross margin | -2.9% | 26.3% | 26.6% | 45.0% | 52.8% | 57.5% | 59.7% | 64.2% |
| R&D | $550.0K | $1.0M | $2.1M | $5.3M | $6.0M | $4.0M | $3.3M | $2.9M |
| Operating income | −$11.3M | −$15.3M | −$18.0M | −$32.6M | −$31.1M | −$18.9M | −$16.3M | −$7.9M |
| EBITDA | −$10.7M | −$14.9M | −$17.7M | −$32.3M | −$30.9M | −$16.5M | −$16.2M | $112.0K |
| Net income | −$11.4M | −$15.2M | −$17.9M | −$31.7M | −$29.9M | −$16.7M | −$13.1M | −$12.8M |
| Net margin | -372.5% | -335.8% | -385.0% | -465.5% | -365.2% | -182.3% | -142.6% | -138.7% |
| EPS (diluted) | -2.43 | -2.57 | -2.67 | -4.28 | -3.85 | -1.81 | -0.93 | -0.37 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $33M | $-0.26 | $-0.26–$-0.26 | 1 |
| 2027 | $75M | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds AWH.
No tracked institution reports a position in AWH as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-05-12 | 1-for-15reverse |
| 2014-05-23 | 3-for-1 |
| 2008-03-04 | 1-for-10reverse |
No one on the platform has traded AWH yet.
| $3M |
| — |
| DMTKQDermTech, Inc. | $0.00 | +0.00% | $3496 | — |
| MDVLMedAvail Holdings, Inc. | $1.80 | -43.22% | $3M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.1× sales vs its 4.7× historical median P/S.
Fair value ≈ $3.53 · price $0.08 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.